n (%)
|
183 (35)
|
345 (65)
|
% male
|
53.0
|
53.0
|
Age (years)*
|
22.9 ± 15.5
|
55.8 ± 16.6
|
Weight (kg)*
|
67.7 ± 2.7
|
85.3 ± 2.2
|
Baseline HbA1c *†
|
9.4 ± 1.6
|
9.3 ± 1.5
|
Duration of diabetes (years)‡
|
7.9 ± 8.7
|
8.1 ± 6.7
|
Number of co-morbidities§
|
2.5 ± 2.4
|
2.4 ± 1.9
|
Premix insulin only (%)
|
61%
|
48%
|
Premix insulin with OAD (%)
|
0%
|
38%
|
Premix + short acting insulin (%)
|
25%
|
16%
|
Premix + basal insulin (%)
|
8%
|
5%
|
Premix + short acting + basal insulin (%)
|
2%
|
3%
|
Premix + other insulin +/-OADs (%)
|
0%
|
2%
|
OADs per patient before starting insulin therapy*¶
|
-
|
0.4 ± 0.5
|
Hypoglycaemia episodes in 3 month period*||
| | |
No. episodes
|
38
|
72
|
Mean no. episodes per patient
|
0.21
|
0.21
|